Paratek Pharma Inc
(PRTK)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -89,069 | -111,636 | -70,860 | -17,835 | -4,653 |
| Depreciation Amortization | 1,268 | 2,303 | 714 | 196 | 98 |
| Accounts receivable | -4,833 | 4,960 | -2,705 | -4,764 | 203 |
| Other Working Capital | -8,240 | 4,547 | 10,537 | -11,507 | 885 |
| Other Operating Activity | 22,300 | 5,728 | 7,632 | 15,377 | -2,892 |
| Operating Cash Flow | $-78,574 | $-94,098 | $-54,682 | $-18,533 | $-6,359 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -49,039 | -75,693 | N/A | N/A | N/A |
| PPE Investments | -1,117 | -690 | -856 | N/A | N/A |
| Sale Of Investment | 7,499 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 1,626 | 253 | 13,667 | 396 |
| Investing Cash Flow | $-42,657 | $-74,757 | $-603 | $13,667 | $396 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 20,235 | 19,574 | 19,205 | 10,580 | 4,806 |
| Debt Repayment | N/A | N/A | N/A | N/A | 1,352 |
| Common Stock Issued | 82,795 | 70,941 | 71,526 | 89,761 | 1 |
| Other Financing Activity | 0 | 0 | 0 | -831 | 0 |
| Financing Cash Flow | $103,030 | $90,515 | $90,731 | $99,510 | $6,159 |
| Beginning Cash Position | 54,029 | 131,302 | 95,856 | 1,212 | 1,016 |
| End Cash Position | 35,828 | 52,962 | 131,302 | 95,856 | 1,212 |
| Net Cash Flow | $-18,201 | $-78,340 | $35,446 | $94,644 | $196 |
| Free Cash Flow | |||||
| Operating Cash Flow | -78,574 | -94,098 | -54,682 | -18,533 | -6,359 |
| Capital Expenditure | -1,117 | -690 | -856 | N/A | N/A |
| Free Cash Flow | -79,691 | -94,788 | -55,538 | -18,533 | -6,359 |